Scavenger Receptors, Class B
"Scavenger Receptors, Class B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of scavenger receptors that are predominately localized to CAVEOLAE of the PLASMA MEMBRANE and bind HIGH DENSITY LIPOPROTEINS.
Descriptor ID |
D051122
|
MeSH Number(s) |
D12.776.543.750.705.940.625 D12.776.543.750.710.450.750.625
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Scavenger Receptors, Class B".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Scavenger [D12.776.543.750.705.940]
- Scavenger Receptors, Class B [D12.776.543.750.705.940.625]
- Receptors, Lipoprotein [D12.776.543.750.710]
- Receptors, LDL [D12.776.543.750.710.450]
- Receptors, Scavenger [D12.776.543.750.710.450.750]
- Scavenger Receptors, Class B [D12.776.543.750.710.450.750.625]
Below are MeSH descriptors whose meaning is more specific than "Scavenger Receptors, Class B".
This graph shows the total number of publications written about "Scavenger Receptors, Class B" by people in this website by year, and whether "Scavenger Receptors, Class B" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2019 | 1 | 1 | 2 |
2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Scavenger Receptors, Class B" by people in Profiles.
-
Elongated PEO-based nanoparticles bind the high-density lipoprotein (HDL) receptor scavenger receptor class B I (SR-BI). J Control Release. 2021 09 10; 337:448-457.
-
HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat Metab. 2020 12; 2(12):1391-1400.
-
Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning. Viruses. 2020 09 26; 12(10).
-
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1. J Virol. 2019 11 15; 93(22).
-
The expression of hSR-B1 on platelets of patients with coronary artery disease (CAD). Clin Hemorheol Microcirc. 2019; 71(1):9-15.
-
Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load. J Hepatol. 2017 08; 67(2):237-245.
-
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents. Hepatology. 2014 Nov; 60(5):1508-18.
-
Atherosclerosis and the antiphospholipid syndrome: a link unravelled? Lupus. 1998; 7 Suppl 2:S140-3.